However, we have shown that in response to 4NQO treatment Krt76−/− mice are more predisposed to developing tumours in those sites where Krt76 is normally expressed, namely the tongue and squamous stomach (Fig. 5f, g). The gene discussed is KRT76; the disease is neoplasm.